Agarose Enhances the Viability of Intraperitoneally Implanted Microencapsulated L929 Fibroblasts
暂无分享,去创建一个
[1] R. Lanza,et al. Transplantation of encapsulated cells and tissues. , 1997, Surgery.
[2] F T Gentile,et al. Poly(ethylene oxide)‐grafted thermoplastic membranes for use as cellular hybrid bio‐artificial organs in the central nervous system , 1994, Biotechnology and bioengineering.
[3] M. Sefton,et al. Secretion of recombinant proteins from hydroxyethyl methacrylate‐methyl methacrylate capsules , 1996, Biotechnology and bioengineering.
[4] H Yang,et al. Comparative studies of in vitro and in vivo function of three different shaped bioartificial pancreases made of agarose hydrogel. , 1994, Biomaterials.
[5] M. Sefton,et al. Metabolic Activity and Proliferation of Cho Cells in Hydroxyethyl Methacrylate-Methyl Methacrylate (Hema-Mma) Microcapsules , 1993, Cell transplantation.
[6] J. Babensee. Morphological assessment of HEMA-MMA microcapsules for liver cell transplantation , 1996 .
[7] M. Sefton,et al. Microencapsulation of viable hepatocytes in HEMA-MMA microcapsules: a preliminary study. , 1993, Biomaterials.
[8] N. Déglon,et al. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. , 1996, Human gene therapy.
[9] R. L. Broughton,et al. Preparation and characterization of thermoplastic polymers from hydroxyalkyl methacrylates , 1987 .
[10] T. Chang,et al. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. , 1988, Biomaterials, artificial cells, and artificial organs.
[11] Myriam Schluep,et al. Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.
[12] M. Sefton,et al. Protein delivery by microencapsulated cells , 1993 .
[13] T M Chang. Artificial Cells and Bioencapsulation in Bioartificial Organs a , 1997, Annals of the New York Academy of Sciences.
[14] M. Sefton,et al. Viability and protein secretion from human Hepatoma (HepG2) cells encapsulated in 400‐μm polyacrylate microcapsules by submerged nozzle–liquid jet extrusion , 1994, Biotechnology and bioengineering.
[15] H. Hahn,et al. Biocompatibility and Immunology in the Encapsulation of Islets of Langerhans (Bioartificial Pancreas) , 1996, The International journal of artificial organs.
[16] M. Sefton,et al. Making microencapsulation work: conformal coating, immobilization gels and in vivo performance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[17] M. Sefton,et al. Methods for Microencapsulation with HEMA-MMA. , 1999, Methods in molecular medicine.
[18] J. Nobrega,et al. HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain: biocompatibility assessment using [3H]PK11195 as a marker for gliosis. , 1998, Biomaterials.
[19] P. Soon-Shiong,et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation , 1994, The Lancet.
[20] P. Aebischer,et al. Immunoisolated Xenogeneic Chromaffin Cell Therapy for Chronic Pain: Initial Clinical Experience , 1996 .
[21] M. Sefton,et al. Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate--methyl methacrylate copolymer. , 1996, Biomaterials.
[22] J. Leonard,et al. Retroviral Vectors for Production of Interleukin‐12 in the Bone Marrow to Induce a Graft‐Versus‐Leukemia Effect a , 1996, Annals of the New York Academy of Sciences.
[23] M. Sefton,et al. Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel. , 1992, Journal of biomedical materials research.
[24] T. Chang,et al. The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection. , 1991, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.